Human Suppressors Of Cytokine Signaling 1 (SOCS1) ELISA Kit

Product description

Description

Order Human Suppressors Of Cytokine Signaling 1 SOCS1 ELISA Kit 01018329232 at Gentaur Suppressors Of Cytokine Signaling 1 (SOCS1)

Price

797 EUR

Size

96 Tests

Catalog no

RD-SOCS1-Hu

Details

Gene ID

8651

UniProtKB

O15524

Experimental Method

sandwich

Shelf Life

12 months

Sensitivity

0.113ng/mL

Detection Range

0.312-20ng/mL

Species Reactivity

Homo sapiens human

Test

ELISA Enzyme-linked immunosorbent assays Code 90320007 SNOMED

Recommended Sample Type

tissue homogenates, cell lysates and other biological fluids.

Note

This product is available in other size, contact us for more information

Alternatives

CIS1,CISH1,JAB,SOCS-1,SSI-1,SSI1,TIP3,JAK-binding protein,STAT-induced STAT inhibitor 1,Tec-interacting protein 3

Properties

E05 478 566 350 170 or Enzyme-Linked Immunosorbent Assays,E05 478 566 350 170 or Enzyme-Linked Immunosorbent Assays,Human proteins, cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies. Modern humans (Homo sapiens, primarily ssp. Homo sapiens sapiens). Depending on the epitopes used human ELISA kits can be cross reactive to many other species. Mainly analyzed are human serum, plasma, urine, saliva, human cell culture supernatants and biological samples.

Description

Cytokines and Chemokines are chemotaxis related small proteins between 5 to 20 kDa.Cell nucleus signaling proteins and molecules are part of a complex system of communication that governs basic cellular activities and coordinates cell actions. The ability of cells to perceive and correctly respond to their microenvironment is the basis of development, tissue repair, and immunity as well as normal tissue homeostasis. Errors in cellular information processing are responsible for diseases such as cancer, autoimmunity, and diabetes. By understanding cell signaling, diseases may be treated effectively and, theoretically, artificial tissues may be created.